Literature DB >> 6971071

Age and sex related levels of albumin, ceruloplasmin, alpha 1 antitrypsin, alpha 1 acid glycoprotein, and transferrin.

C W Denko, P Gabriel.   

Abstract

Serum levels of albumin (alb), ceruloplasmin (Cp), alpha 1-antitrypsin (AT), alpha 1-acid glycoprotein (AGP) and transferrin (Tf) were quantitatively determined by electroimmunodiffusion in 50 normal men and 75 normal women of varying ages. Alb, Cp and Tf are carrier proteins, AT is a protease inhibitor, and AGPs are acute phase reactants, with protective functions in inflammation. Subjects were grouped as follows: 20 to 44 years, 45 to 54 (an average statistical age at menopause +/- 5 years), and over 55. Differences related to sex and age were noted. These values are to serve, however, as controls for studies of rheumatic disorders in which sex and age are significant factors in demography.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971071

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  11 in total

1.  Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Authors:  N Widmer; L A Decosterd; C Csajka; S Leyvraz; M A Duchosal; A Rosselet; B Rochat; C B Eap; H Henry; J Biollaz; T Buclin
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

2.  Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors:  Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

3.  A new delineation of the congeries of osteoarthritis.

Authors:  C W Denko; P Gabriel
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

4.  Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.

Authors:  Amina Haouala; Nicolas Widmer; Monia Guidi; Michael Montemurro; Serge Leyvraz; Thierry Buclin; Chin B Eap; Laurent A Decosterd; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

Review 5.  Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy.

Authors:  Joyce Oi Yan Chan; Marie Moullet; Beth Williamson; Rosalinda H Arends; Venkatesh Pilla Reddy
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

6.  Pethidine binding to blood cells and plasma proteins in old and young subjects.

Authors:  L Holmberg; I Odar-Cederlöf; J L Nilsson; M Ehrnebo; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.

Authors:  J W Paxton; R H Briant
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

8.  beta-Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders.

Authors:  C W Denko; J Aponte; P Gabriel; M Petricevic
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

9.  Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).

Authors:  Michael R Bennett; Qing Ma; Jun Ying; Prasad Devarajan; Hermine Brunner
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-13       Impact factor: 3.054

Review 10.  Alpha-1-antitrypsin: A possible host protective factor against Covid-19.

Authors:  Mariana Braccialli de Loyola; Thaís Tereza Aguiar Dos Reis; Guilherme Xavier Lyra Malcher de Oliveira; Julys da Fonseca Palmeira; Gustavo A Argañaraz; Enrique R Argañaraz
Journal:  Rev Med Virol       Date:  2020-08-26       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.